Lipid-based surface engineering of PLGA nanoparticles for drug and gene delivery applications

다국어 초록 (Multilingual Abstract)

The use of poly(lactic-co-glycolic acid) (PLGA)-based nanocarriers presents several major challenges, including their synthetic hydrophobic surface, low transfection efficiency, short circulation half-life, and nonspecific tissue distribution. Numerous engineering strategies have been employed to overcome these problems, with lipid-based surface functionalization of PLGA nanoparticles (NPs) showing promising results in the development of PLGA-based clinical nanomedicines. Surface engineering with different lipids enhances the target specificity of the carrier and improves its physicochemical properties as well as NP-cell associations, such as cellular membrane permeability, immune responses, and long circulation half-life in vivo. This review focuses on recent advances in the lipid-based surface engineering of PLGA NPs for drug and gene delivery applications.

참고문헌 (Reference)

1 Hu C-MJ, "‘Marker-of-self’functionalization of nanoscale particles through a top-down cellular membrane coating approach" 5 : 2664-2668, 2013

2 Dehaini D, "Ultra-small lipid-polymer hybrid nanoparticles for tumorpenetrating drug delivery" 8 : 14411-14419, 2016

3 Zheng Y, "Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7α-APTADD to breast cancer cells" 390 : 234-241, 2010

4 van Hoogevest P, "The use of natural and synthetic phospholipids as pharmaceutical excipients" 116 : 1088-1107, 2014

5 Cheow WS, "The roles of lipid in anti-biofilm efficacy of lipid-polymer hybrid nanoparticles encapsulating antibiotics" 389 : 158-165, 2011

6 Sengupta S, "Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system" 436 : 568-572, 2005

7 Arumugam S, "Targeting fatty acid metabolism in heart failure: is it a suitable therapeutic approach?" 21 : 1003-1008, 2016

8 Clawson C, "Synthesis and characterization of lipid-polymer hybrid nanoparticles with pH-triggered poly(ethylene glycol)shedding" 27 : 10556-10561, 2011

9 Rajendiran Jagathesh Chandra Bose, "Surface modification of polymeric nanoparticles with human adipose derived stem cell membranes AdMSCs" Frontiers Media SA 4 : 2016

10 Y-k G, "Strategies in biomimetic surface engineering of nanoparticles for biomedical applications" 4 : 360-368, 2012

11 Birajdar MS, "Sonication-triggered zero-order release by uncorking core-shell nanofibers" 288 : 1-8, 2016

12 Yang X-Z, "Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA" 6 : 4955-4965, 2012

13 Zhang L, "Self-assembled lipid − polymer hybrid nanoparticles : a robust drug delivery platform" 2 : 1696-1702, 2008

14 Cen Chen, "Research trends in biomimetic medical materials for tissue engineering: 3D bioprinting, surface modification, nano/micro-technology and clinical aspects in tissue engineering of cartilage and bone" 한국생체재료학회 20 (20): 96-102, 2016

15 Rao L, "Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance" 11 : 6225-6236, 2015

16 Fang RH, "Quick synthesis of lipid − polymer hybrid nanoparticles with low polydispersity using a single-step sonication method" 26 : 16958-16962, 2010

17 Bose RJC, "Preparation of cationic lipid layered PLGA hybrid nanoparticles for gene delivery" 213 : e92-e93, 2015

18 Li Li, "Polymeric nanocarrier systems for photodynamic therapy" 한국생체재료학회 19 (19): 01-14, 2015

19 Udomluck N, "Poly (N-isopropylacrylamide)-based nanogels encapsulating gold nanoparticles for DNA delivery" 213 : e85-, 2015

20 Anselmo AC, "Platelet-like nanoparticles : mimicking shape, flexibility, and surface biology of platelets to target vascular injuries" 8 : 11243-11253, 2014

21 Zhao P, "Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core : in vitro and in vivo evaluation" 81 : 248-256, 2012

22 Danhier F, "PLGA-based nanoparticles : an overview of biomedical applications" 161 : 505-522, 2012

23 Perry JL, "PEGylated PRINT nanoparticles : the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics" 12 : 5304-5310, 2012

24 Zhong Q, "Optimization of DNA delivery by three classes of hybrid nanoparticle/DNA complexes" 8 : 6-, 2010

25 Hu C-MJ, "Nanoparticle biointerfacing by platelet membrane cloaking" 526 : 118-121, 2015

26 Jokerst JV, "Nanoparticle PEGylation for imaging and therapy" 6 : 715-728, 2011

27 Farokhzad OC, "Nanomedicine : developing smarter therapeutic and diagnostic modalities" 58 : 1456-1459, 2006

28 Krishnamurthy S, "Monocyte Cell Membrane-derived Nanoghosts for Targeted Cancer Therapy" 8 (8): 6981-6985, 2016

29 Duraisamy K, "Methods of detecting cervical cancer" 5 : 226-232, 2011

30 Eibl H, "Medical application of synthetic phospholipids as liposomes and drugs" 5 : 131-148, 1995

31 Kim Y, "Mass production and size control of lipid-polymer hybrid nanoparticles through controlled microvortices" 12 : 3587-3591, 2012

32 Monteiro N, "Liposomes in tissue engineering and regenerative medicine" 11 : 20140459-, 2014

33 Hadinoto K, "Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform : a review" 85 : 427-443, 2013

34 Zhang L, "Lipid-polymer hybrid nanoparticles : synthesis, characterization and applications" 1 : 163-173, 2010

35 Fang RH, "Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles" 5 : 8884-8888, 2013

36 Rajendran JC Bose, "Lipid polymer hybrid nanospheres encapsulating antiproliferative agents for stent applications" 한국공업화학회 36 : 284-292, 2016

37 Duraisamy K, "J Gastroenterol Hepatol" Wiley-Blackwell 155-156, 2012

38 Ramesh Subbiah, "Investigation of the changes of biophysical/mechanical characteristics of differentiating preosteoblasts in vitro" 한국생체재료학회 19 (19): 210-217, 2015

39 Bose RJC, "Influence of cationic lipid concentration on properties of lipid-polymer hybrid nanospheres for gene delivery" 10 : 5367-5382, 2015

40 Chan JM, "In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles" 108 : 19347-19352, 2011

41 Alexis F, "Factors affecting the clearance and biodistribution of polymeric nanoparticles" 5 : 505-515, 2008

42 Cheow WS, "Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles" 85 : 214-220, 2011

43 Bose RJC, "Fabrication and characterization of PLGA polymer-lipid hybrid nanoparticle for gene delivery platform" 60-, 2014

44 D. Krishnakumar, "Evaluation of mucoadhesive nanoparticle based nasal vaccine" 한국약제학회 42 (42): 315-326, 2012

45 Aryal S, "Erythrocyte membrane-cloaked polymeric nanoparticles for controlled drug loading and release" 8 : 1271-1280, 2013

46 Hu C-MJ, "Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform" 108 : 10980-10985, 2011

47 Hu Y, "Engineering the lipid layer of lipid-PLGA hybrid nanoparticles for enhanced in vitro cellular uptake and improved stability" 28 : 149-159, 2015

48 Mieszawska AJ, "Engineering of lipid-coated PLGA nanoparticles with a tunable payload of diagnostically active nanocrystals for medical imaging" 48 : 5835-5837, 2012

49 Jun Yang, "Engineered biomaterials for development of nucleic acid vaccines" 한국생체재료학회 19 (19): 21-29, 2015

50 Shi J, "Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering RNA delivery" 123 : 7165-7169, 2011

51 Shi J, "Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering RNA delivery" 50 : 7027-7031, 2011

52 Hasan W, "Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer" 12 : 287-292, 2011

53 Mandal B, "Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform" 9 : 474-491, 2013

54 Aryal S, "Combinatorial Drug Conjugation Enables Nanoparticle Dual‐Drug Delivery" 6 : 1442-1448, 2010

55 Lee J-J, "Cholesterol-modified poly (lactide-co-glycolide) nanoparticles for tumor-targeted drug delivery" 509 (509): 483-491, 2016

56 Wang AZ, "ChemoRad nanoparticles : a novel multifunctional nanoparticle platform for targeted delivery of concurrent chemoradiation" 5 : 361-368, 2010

57 Luk BT, "Cell membrane-camouflaged nanoparticles for drug delivery" 220 : 600-607, 2015

58 Fang RH, "Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery" 14 : 2181-2188, 2014

59 RHe A, "Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery" 14 : 2181-2188, 2014

60 Parodi A, "Biomimetic functionalization with leukocyte membranes imparts cell like functions to synthetic particles" 8 : 61-, 2013

61 Dudia A, "Biofunctionalized Lipid −Polymer Hybrid Nanocontainers with Controlled Permeability" 8 : 1105-1110, 2008

62 Bose RJC, "Biofucntionalized nanoparticles : an emerging drug delivery platform for various disease treatments" 21 (21): 1303-1312, 2016

63 Luderer F, "Biodegradable sirolimus-loaded poly(lactide)nanoparticles as drug delivery system for the prevention of in-stent restenosis in coronary stent application" 25 : 851-875, 2011

64 Yoo J-W, "Bio-inspired, bioengineered and biomimetic drug delivery carriers" 10 : 521-535, 2011